CalliSpheres(®) microsphere transarterial chemoembolization combined with (125)I brachytherapy for patients with non–small‐cell lung cancer liver metastases

OBJECTIVE: Poor prognosis and limited treatments of liver metastases from non–small‐cell lung cancer (NSCLC) after radical surgery are critical issues. The current study aimed to evaluate the efficacy and safety of CalliSpheres(®) microsphere transarterial chemoembolization (CSM-TACE) plus (125)I br...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Guangsheng, Liu, Song, Liu, Ying, Li, Xiang, Yu, Guangji, Zhang, Yuewei, Bian, Jie, Wu, Jianlin, Zhou, Jun, Gao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413194/
https://www.ncbi.nlm.nih.gov/pubmed/36033546
http://dx.doi.org/10.3389/fonc.2022.882061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413194/
https://www.ncbi.nlm.nih.gov/pubmed/36033546
http://dx.doi.org/10.3389/fonc.2022.882061

Ejemplares similares